mikeannDOWNTREND. Further weakness expected. NEXT SUPPORT 0.61
TMC Life Sciences may experience further correction after closing below the MYR0.69 level. Traders may expect further weakness if the stock stays below this level in the near term, with the next support level anticipated at MY0.655, followed by MYR0.61. The stock may trade sideways if it recovers back above MYR0.69, while bullish bias is likely to return if it recovers above the MYR0.74 level.